NM_001142854.2:c.577G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001142854.2(SPATC1L):​c.577G>A​(p.Ala193Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0751 in 1,589,382 control chromosomes in the GnomAD database, including 5,339 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A193V) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.061 ( 392 hom., cov: 32)
Exomes 𝑓: 0.077 ( 4947 hom. )

Consequence

SPATC1L
NM_001142854.2 missense

Scores

1
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.920

Publications

9 publications found
Variant links:
Genes affected
SPATC1L (HGNC:1298): (spermatogenesis and centriole associated 1 like) Enables identical protein binding activity. Predicted to act upstream of or within several processes, including actin polymerization or depolymerization; positive regulation of cAMP-dependent protein kinase activity; and positive regulation of protein kinase A signaling. Predicted to be located in sperm connecting piece. Predicted to be active in centrosome. [provided by Alliance of Genome Resources, Apr 2022]
SPATC1L Gene-Disease associations (from GenCC):
  • hearing loss disorder
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0013727844).
BP6
Variant 21-46162035-C-T is Benign according to our data. Variant chr21-46162035-C-T is described in ClinVar as Benign. ClinVar VariationId is 403470.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0822 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SPATC1LNM_001142854.2 linkc.577G>A p.Ala193Thr missense_variant Exon 4 of 5 ENST00000291672.6 NP_001136326.1
SPATC1LNM_032261.5 linkc.115G>A p.Ala39Thr missense_variant Exon 3 of 4 NP_115637.3
SPATC1LXM_005261188.6 linkc.577G>A p.Ala193Thr missense_variant Exon 4 of 5 XP_005261245.1 Q9H0A9-1
SPATC1LXM_011529756.3 linkc.235G>A p.Ala79Thr missense_variant Exon 2 of 3 XP_011528058.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SPATC1LENST00000291672.6 linkc.577G>A p.Ala193Thr missense_variant Exon 4 of 5 2 NM_001142854.2 ENSP00000291672.5 Q9H0A9-1
SPATC1LENST00000330205.10 linkc.115G>A p.Ala39Thr missense_variant Exon 3 of 4 1 ENSP00000333869.6 Q9H0A9-2

Frequencies

GnomAD3 genomes
AF:
0.0608
AC:
9242
AN:
152058
Hom.:
392
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0170
Gnomad AMI
AF:
0.0768
Gnomad AMR
AF:
0.0636
Gnomad ASJ
AF:
0.0859
Gnomad EAS
AF:
0.0116
Gnomad SAS
AF:
0.0453
Gnomad FIN
AF:
0.100
Gnomad MID
AF:
0.0506
Gnomad NFE
AF:
0.0840
Gnomad OTH
AF:
0.0649
GnomAD2 exomes
AF:
0.0650
AC:
13135
AN:
201988
AF XY:
0.0669
show subpopulations
Gnomad AFR exome
AF:
0.0145
Gnomad AMR exome
AF:
0.0363
Gnomad ASJ exome
AF:
0.0864
Gnomad EAS exome
AF:
0.0155
Gnomad FIN exome
AF:
0.0916
Gnomad NFE exome
AF:
0.0884
Gnomad OTH exome
AF:
0.0723
GnomAD4 exome
AF:
0.0766
AC:
110119
AN:
1437208
Hom.:
4947
Cov.:
35
AF XY:
0.0762
AC XY:
54379
AN XY:
713526
show subpopulations
African (AFR)
AF:
0.0142
AC:
471
AN:
33204
American (AMR)
AF:
0.0381
AC:
1604
AN:
42060
Ashkenazi Jewish (ASJ)
AF:
0.0844
AC:
2166
AN:
25676
East Asian (EAS)
AF:
0.0122
AC:
476
AN:
38864
South Asian (SAS)
AF:
0.0545
AC:
4555
AN:
83646
European-Finnish (FIN)
AF:
0.0922
AC:
4258
AN:
46172
Middle Eastern (MID)
AF:
0.0625
AC:
359
AN:
5744
European-Non Finnish (NFE)
AF:
0.0836
AC:
92153
AN:
1102316
Other (OTH)
AF:
0.0685
AC:
4077
AN:
59526
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
6231
12462
18693
24924
31155
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3298
6596
9894
13192
16490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0607
AC:
9239
AN:
152174
Hom.:
392
Cov.:
32
AF XY:
0.0610
AC XY:
4542
AN XY:
74404
show subpopulations
African (AFR)
AF:
0.0169
AC:
703
AN:
41576
American (AMR)
AF:
0.0635
AC:
972
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.0859
AC:
298
AN:
3470
East Asian (EAS)
AF:
0.0114
AC:
59
AN:
5162
South Asian (SAS)
AF:
0.0449
AC:
217
AN:
4830
European-Finnish (FIN)
AF:
0.100
AC:
1060
AN:
10594
Middle Eastern (MID)
AF:
0.0544
AC:
16
AN:
294
European-Non Finnish (NFE)
AF:
0.0840
AC:
5708
AN:
67920
Other (OTH)
AF:
0.0643
AC:
136
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
444
889
1333
1778
2222
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
110
220
330
440
550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0759
Hom.:
659
Bravo
AF:
0.0558
TwinsUK
AF:
0.0885
AC:
328
ALSPAC
AF:
0.0815
AC:
314
ESP6500AA
AF:
0.0162
AC:
71
ESP6500EA
AF:
0.0851
AC:
729
ExAC
AF:
0.0600
AC:
7149
Asia WGS
AF:
0.0200
AC:
68
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Apr 19, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 30177775) -

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.67
T
BayesDel_noAF
Benign
-0.67
CADD
Benign
21
DANN
Uncertain
1.0
DEOGEN2
Benign
0.0060
.;T
Eigen
Benign
-0.62
Eigen_PC
Benign
-0.53
FATHMM_MKL
Benign
0.14
N
MetaRNN
Benign
0.0014
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.0
.;N
PhyloP100
0.92
PrimateAI
Benign
0.42
T
PROVEAN
Benign
-0.090
N;N
REVEL
Benign
0.015
Sift
Benign
0.15
T;T
Sift4G
Benign
0.24
T;T
Polyphen
0.16
.;B
Vest4
0.16
MPC
0.19
ClinPred
0.0039
T
GERP RS
2.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.059
gMVP
0.18
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs113146399; hg19: chr21-47581949; COSMIC: COSV52432453; API